Key result
Sympathomimetic amines like norepinephrine and isoproterenol may benefit systemic blood pressure in cardiogenic shock, but experimental observations suggest harmful effects on the regional myocardium.
Why the study?
Do sympathomimetic amines (norepinephrine and isoproterenol) improve hemodynamics without harming regional myocardium in cardiogenic shock?
Do sympathomimetic amines (norepinephrine and isoproterenol) improve hemodynamics without harming regional myocardium in cardiogenic shock?
While sympathomimetic amines improve systemic blood pressure in cardiogenic shock, their potential harmful effects on regional myocardial blood flow warrant careful individualized investigation.
Answers are grounded in this paper and cite their sources.
Potential myocardial harm with norepinephrine/isoproterenol in cardiogenic shock; leaves open optimal sympathomimetic selection by coronary status.
Our discussion on the medical treatment of cardiogenic shock:"Several sympathomimetic amines are preferable provided they are carefully used. Norepinephrine and isoproterenol are apparently beneficial for systemic blood pressure. However, our experimental observations suggest their harmful action on the regional myocardium and dependence of their action up on regional myocardial blood flow on severity of coronary artery constriction. Therefore, we consider that further detailed investigations on their action on myocardial blood flow in individual patient are necessitated.
No takes yet. Share an insight, caveat, or question.
Uchida et al. (1974) conducted a review in Cardiogenic shock. Sympathomimetic amines (norepinephrine and isoproterenol) was evaluated. Sympathomimetic amines like norepinephrine and isoproterenol may benefit systemic blood pressure in cardiogenic shock, but experimental observations suggest harmful effects on the regional myocardium.
Synapse has enriched 10 related papers. Consider them for comparative context: